Simon N.R. Harford Albireo Pharma, Inc. (ALBO) insider trading activity

Simon N.R. Harford is CFO and Treasurer of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 13,739 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Simon N.R. Harford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	13,739 Reduced 100.0%	0 Common Stock
Jan 23 2023	SELL Open market or private sale	$4,467 $43.8 p/Share	102 Reduced 0.31%	32,689 Common Stock
Jan 19 2023	SELL Open market or private sale	$77,788 $43.8 p/Share	1,776 Reduced 5.14%	32,791 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	55,000 Added 38.55%	87,689 Common Stock
Oct 24 2022	SELL Open market or private sale	$2,036 $19.58 p/Share	104 Reduced 0.31%	33,295 Common Stock
Oct 11 2022	SELL Open market or private sale	$1,903 $23.79 p/Share	80 Reduced 0.24%	33,399 Common Stock
Jul 22 2022	SELL Open market or private sale	$2,615 $24.67 p/Share	106 Reduced 0.32%	33,479 Common Stock
Jul 12 2022	SELL Open market or private sale	$2,283 $24.03 p/Share	95 Reduced 0.28%	33,585 Common Stock
Apr 22 2022	SELL Open market or private sale	$3,391 $32.92 p/Share	103 Reduced 0.3%	33,680 Common Stock
Apr 11 2022	SELL Open market or private sale	$3,431 $35.74 p/Share	96 Reduced 0.28%	33,783 Common Stock
Jan 24 2022	SELL Open market or private sale	$10,350 $24.88 p/Share	416 Reduced 1.21%	33,879 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	21,600 Added 38.64%	34,295 Common Stock
Jan 11 2022	SELL Open market or private sale	$2,880 $25.95 p/Share	111 Reduced 0.87%	12,695 Common Stock
Oct 11 2021	SELL Open market or private sale	$2,811 $30.23 p/Share	93 Reduced 0.73%	12,614 Common Stock
Jul 13 2021	SELL Open market or private sale	$3,432 $35.02 p/Share	98 Reduced 0.77%	12,707 Common Stock
Apr 12 2021	SELL Open market or private sale	$2,955 $32.12 p/Share	92 Reduced 0.75%	12,196 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	5,500 Added 35.22%	10,114 Common Stock
Jan 11 2021	SELL Open market or private sale	$4,106 $37.33 p/Share	110 Reduced 2.33%	4,614 Common Stock
Oct 12 2020	SELL Open market or private sale	$3,357 $37.3 p/Share	90 Reduced 1.91%	4,616 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

Chief Financial Officer

SNH

Simon N.R. Harford

CFO and Treasurer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALBO shares.

Notify only if

Value

Insider Trading

Get notified when an Albireo Pharma, Inc. insider buys or sells ALBO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALBIREO PHARMA, INC.

Track Activities on ALBO

Account